Critical care in cardiovascular medicine

Current Opinion in Pediatrics

Volumn 15, Issue 5, 2003, Pages 443-453

  Ravishankar, Chitra ^a,b   Tabbutt, Sarah ^a   Wernovsky, Gil ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Cardiac intensive care; Cardiopulmonary bypass; Low cardiac output syndrome

Indexed keywords

ADRENALIN; AMRINONE; BERAPROST; BOSENTAN; CARDIOVASCULAR AGENT; CATECHOLAMINE; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; ILOPROST; INOTROPIC AGENT; ISOPRENALINE; LIOTHYRONINE; MILRINONE; NITRIC OXIDE; NORADRENALIN; PHENOXYBENZAMINE; PHOSPHODIESTERASE INHIBITOR; PROSTACYCLIN DERIVATIVE; SILDENAFIL; TOLAZOLINE; VASODILATOR AGENT;

ARTIFICIAL VENTILATION; CARDIOPULMONARY BYPASS; CARDIOVASCULAR RISK; CLINICAL TRIAL; DILUTION; DOPPLER ECHOGRAPHY; DYE DILUTION CURVE; ECHOCARDIOGRAPHY; ELECTROENCEPHALOGRAM; EXTRACORPOREAL OXYGENATION; FORWARD HEART FAILURE; HEART AFTERLOAD; HEART ARRHYTHMIA; HEART ASSIST DEVICE; HEART DISEASE; HEART FAILURE; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEART PRELOAD; HEART RATE; HEART RIGHT LEFT SHUNT; HEMODYNAMIC MONITORING; HUMAN; HYPOTENSION; HYPOTHYROIDISM; IMPEDANCE; INOTROPISM; INTENSIVE CARE; KIDNEY DISEASE; LACTATE BLOOD LEVEL; LUNG INJURY; LUNG TRANSPLANTATION; METHEMOGLOBINEMIA; NEAR INFRARED SPECTROSCOPY; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN SATURATION; PEROPERATIVE CARE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SCINTISCANNING; SEDATION; SIDE EFFECT; THERMODILUTION; THROMBOCYTOPENIA; TONOMETRY;

CARDIAC OUTPUT, LOW; CARDIAC SURGICAL PROCEDURES; CARDIOTONIC AGENTS; CHILD; CRITICAL CARE; DYE DILUTION TECHNIQUE; HEART-ASSIST DEVICES; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; INTRAOPERATIVE CARE; MILRINONE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; VASODILATOR AGENTS;

EID: 0141562232     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200310000-00001     Document Type: Review

References (175)

1. Parr GVS, Blackstone EH, Kirklin JW: Cardiac performance and mortality early after intracardiac surgery in infants and young children. Circulation 1975, 51:867-874.
2. Wernovsky G, Wypji D, Jonas RA, et al.: Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants: a comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995, 92:2226-2235.
3. Kirklin JK, Westaby S, Blackstone EH, et al.: Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983, 86:845-857.
4. Wan S, LeClerc JL, Vincent JL: Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997, 112:676-692.
5. Edmunds LH Jr: Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1998, 66:S12-S16.
6. Menasche P: The inflammatory response to cardiopulmonary bypass and its impact on postoperative myocardial function. Curr Opin Cardiol 1995, 10:597-604.
7. Taggert DP, Hadjinikolas L, Wong K, et al.: Vulnerability of paediatric myocardium to cardiac surgery. Heart 1996, 76:214-217.
8. Butler J, Pathi VL, Paton RD, et al.: Acute-phase responses to cardiopulmonary bypass in children weighing less than 10 kilograms. Ann Thorac Surg 1996, 62:538-542.
9. Hirsch R, Dent CL, Wood MK, et al.: Patterns and potential value of cardiac troponin I elevations after pediatric cardiac operations. Ann Thorac Surg 1998, 65:1394-1399.
10. Immer FF, Stocker F, Seiler AM, et al.: Troponin I for prediction of early postoperative course after pediatric cardiac surgery. J Am Coll Cardiol 1999, 33:1719-1723.
11. Hovels-Gurich HH, Vazquez-Jimenez JF, Silvestri A, et al.: Production of proinflammatory cytokines and myocardial dysfunction after arterial switch operation in neonates with transposition of the great arteries. J Thorac Cardiovasc Surg 2002, 124:811-820. Serum interleukin-6, interleukin-8, and cardiac troponin T levels were measured before and after an arterial switch operation in 63 consecutive neonates with transposition of the great arteries. Patients with myocardial dysfunction had significantly higher cardiac troponin T levels and interleukin-6 and -8 levels than patients without myocardial dysfunction.
12. Barratt-Boyes BG, Simpson M, Neutze JM: Intracardiac surgery in neonates and infants using deep hypothermia with surface cooling and limited cardiopulmonary bypass. Circulation 1971, 43(suppl):125-130.
13. Castaneda AR, Lamberti J, Sade RM, et al.: Open-heart surgery during the first three months of life. J Thorac Cardiovasc Surg 1974, 68:719-731.
14. Newburger JW, Jonas RA, Wernovsky G, et al.: A comparison of the perioperative neurologic effects of hypothermic circulatory arrest versus low-flow cardiopulmonary bypass in infant heart surgery. N Engl J Med 1993, 329:1057-1064.
15. Bellinger DC, Jonas RA, Rappaport LA, et al.: Developmental and neurologic status of children after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass. N Engl J Med 1995, 332:549-555.
16. Bellinger DC, Wypij D, Kuban KC, et al.: Developmental and neurologic status of children at 4 years of age after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass. Circulation 1999, 100:526-532.
17. Naik SK, Knight A, Elliott MJ, et al.: A randomized study of a modified technique of ultrafiltration during pediatric open-heart surgery. Circulation 1991, 84(suppl 3):422-431.
18. Elliott MJ: Ultrafiltration and modified ultrafiltration in pediatric open heart operations. Ann Thorac Surg 1993, 56:1518-1522.
19. Koutlas TC, Gaynor JW, Nicholson SC, et al.: Modified ultrafiltration reduces postoperative morbidity after cavopulmonary connection. Ann Thorac Surg 1997, 64:37-42.
20. Chaturvedi RR, Shore DF, White PA, et al.: Modified ultrafiltration improves global left ventricular systolic function after open-heart surgery in infants and children. Eur J Cardiothorac Surg 1999, 15:742-746.
21. Darling D, Nanry K, Shearer I, et al.: Technique of paediatric modified ultrafiltration: 1996 survey results. Perfusion 1998, 13:93-103.
22. Thompson LD, McElhinny DB, Findlay P, et al.: A prospective randomized study comparing volume-standardized modified and conventional ultrafiltration in pediatric open-heart surgery. J Thorac Cardiovasc Surg 2001, 122:220-228.
23. Wessel DL: Managing low cardiac output syndrome after congenital heart surgery. Crit Care Med 2001, 29(suppl):220-230.
24. Tibby SM, Hatherill M, Murdoch IA: Capillary refill and core-peripheral temperature gap as indicators of hemodynamic status in pediatric intensive care patients. Arch Dis Child 1999, 80:163-166.
25. Tibby SM, Murdoch IA: Monitoring cardiac function in intensive care. Arch Dis Child 2003, 88:46-52. This article is a comprehensive review of invasive and noninvasive methods of monitoring cardiac output in critically ill children.
26. Tibby SM, Murdoch IA: Measurement of cardiac output and tissue perfusion. Curr Opin Pediatr 2002, 14:303-309. This article is another comprehensive review of direct and indirect methods for measuring cardiac output in the intensive care unit.
27. Hamilton WF, Moore JW, Kinsman JM, et al.: Studies on the circulation: IV. Further analysis of the injection method, and changes in hemodynamics under physiologic and pathologic conditions. Am J Physiol 1932, 99:534-542.
28. Linton RA, Band DM, Haire KM: A new method of measuring cardiac output in man using lithium dilution. Br J Anaesth 1993, 71:262-266.
29. Jonas MM, Tanser SJ: Lithium dilution measurement of cardiac output and arterial pulse waveform analysis: an indicator dilution calibrated beat-by-beat system for continuous estimation of cardiac output. Curr Opin Crit Care 2002, 8:257-261.
30. Linton RA, Jonas MM, Tibby SM, et al.: Cardiac output measured by lithium dilution and transpulmonary thermodilution in patients in a pediatric intensive care unit. Intensive Care Med 2000, 26:1507-1511.
31. Fegler G: Measurement of cardiac output in anesthetized animals by a thermodilution method. Q J Exp Physiol 1954, 39:153-164.
32. Jansen JRC: The thermodilution method for the clinical assessment of cardiac output. Intensive Care Med 1995, 21:691-697.
33. Moodie DS, Feldt RH, Kaye MP, et al.: Measurement of cardiac output by thermodilution: development of accurate measurements at flows applicable to the pediatric patient. J Surg Res 1978, 25:305-311.
34. Nishikawa T, Dohi S: Errors in the measurement of cardiac output by thermodilution. Can J Anaesth 1993, 40:142-153.
35. Levett JM, Replogle RL: Thermodilution cardiac output: a critical analysis and review of the literature. J Surg Res 1979, 27:392-404.
36. Marik PE: Pulmonary artery catheterization and esophageal Doppler monitoring in the intensive care unit. Chest 1999, 116:1085-1091.
37. Jansen JRC, Schreuder JJ, Settels JJ, et al.: An adequate strategy for the thermodilution technique in patients during mechanical ventilation. Intensive Care Med 1990, 16:422-425.
38. Jansen JRC, Schreuder JJ, Punt KD, et al.: Mean cardiac output by thermodilution with a single controlled injection. Crit Care Med 2001, 29:1868-1873.
39. Yelderman ML, Ramsay MA, Quinn MD, et al.: Continuous thermodilution cardiac output measurement in intensive care unit patients. J Cardiothorac Vasc Anesth 1992, 6:270-274.
40. McLuckie A, Murdoch IA, Marsh MJ, et al.: A comparison of pulmonary and femoral artery thermodilution cardiac indices in pediatric intensive care patients. Acta Paediatr 1996, 85:336-338.
41. Tibby SM, Hatherill M, Marsh MJ, et al.: Clinical validation of cardiac output using femoral artery thermodilution with direct Fick in ventilated children and infants. Intensive Care Med 1997, 23:987-991.
42. Wippermann CF, Huth RG, Schmidt FX, et al.: Continuous measurement of cardiac output by the Fick principle in infants and children: comparison with the thermodilution method. Intensive Care Med 1996, 22:467-471.
43. Reddy PS, Curtiss EL, Bell B: Determinants of variation between Fick and indicator dilution estimates of cardiac output during diagnostic catheterization: Fick vs. dye cardiac outputs. J Lab Clin Med 1976, 87:568-576.
44. Hillis LD, Firth BG, Winniford MD: Analysis of factors affecting the variability of Fick versus indicator dilution measurements of cardiac output. Am J Cardiol 1985, 56:764-768.
45. Rudolph AM, Cayler GG: Cardiac catheterization in infants and children. Pediatr Clin North Am 1958, 5:907-943.
46. Rudolph AM: Complications occurring in children. Circulation 1968, 37:59-66.
47. Li J, Andrew B, Schulze-Neick I, et al.: Measured versus estimated oxygen consumption in ventilated patients with congenital heart disease. Crit Care Med 2003, 31:1235-1240. Oxygen consumption was measured by respiratory mass spectrometry and estimated using four standard equations in 126 children with congenital heart disease. In patients undergoing cardiac catheterization, VO2 was overestimated by all equations. In children in the intensive care unit, VO2 was significantly underestimated by three equations and underestimated by one equation. Thus, there was poor agreement between measured and estimated oxygen consumption in sedated, mechanically ventilated children with heart disease during cardiac catheterization and after cardiopulmonary bypass.
48. Chang AC, Kulik TJ, Hickey PR, et al.: Real-time gas-exchange measurement of oxygen consumption in neonates and infants after cardiac surgery. Crit Care Med 1993, 21:1369-1375.
49. Weyland W, Weyland A, Fritz U, et al.: A new pediatric metabolic monitor. Intensive Care Med 1994, 20:51-57.
50. Behrends M, Kernbach M, Brauer A, et al.: In vitro validation of a metabolic monitor for gas exchange measurements in ventilated neonates. Intensive Care Med 2001, 27:228-235.
51. Schulze A, Abubakar K, Gill G, et al.: Pulmonary oxygen consumption: a hypothesis to explain the increase in oxygen consumption of low birth weight infants with lung disease. Intensive Care Med 2001, 27:1636-1642.
52. Alverson DC, Eldridge M, Yabek S, et al. Noninvasive pulsed Doppler determination of cardiac output in neonates and children. J Pediatr 1982, 101:46-50.
53. Sanders SP, Yeager S, Williams RG. Measurement of systemic and pulmonary blood flow and Qp/Qs ratio using Doppler and two-dimensional echocardiography. Am J Cardiol 1983, 51:952-956.
54. Mohan UR, Britto J, Habibi P, et al.: Noninvasive measurement of cardiac output in critically ill children. Pediatr Cardiol 2002, 23:58-61.
55. Colan SD, Borow KM, Neumann A: Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility. J Am Coll Cardiol 1984, 4:715-724.
56. Erlanger J, Hooker DR: An experimental study of blood pressure and of pulse-pressure in man. Johns Hopkins Hosp Rep 1904, 12:145-378.
57. Antonini M, Meloncelli S, Dantimi C, et al.: Haemodynamic study by PiCCO system with brachial artery access during anesthesia for abdominal aortic aneurysm repair. Minerva Anestesiol 2001, 67:447-456.
58. Jansen JRC, Schreuder JJ, Mulier JP, et al.: A comparison of cardiac output derived from the arterial pressure wave against thermodilution in cardiac surgery patients. Br J Anaesth 2001, 87:212-222.
59. Linton NW, Linton RA: Estimation of changes in cardiac output from the arterial blood pressure waveform in the upper limb. Br J Anaesth 2001, 86:486-496.
60. Kubicek WG, Karnegis JN, Patterson RP: Development and evaluation of an impedance cardiac output system. Aerospace Med 1966, 37:1208-1212.
61. Petretta M, Storto G, Ferro A, et al.: Radionuclide monitoring of left ventricular function. J Nucl Cardiol 2001, 8:606-615.
62. Kaji S, Yang PC, Kerr AB, et al.: Rapid evaluation of left ventricular volume and mass without breath holding using real-time interactive cardiac magnetic resonance imaging system. J Am Coll Cardiol 2001, 38:527-533.
63. Rossi AF, Sommer RJ, Lotvin A, et al.: Usefulness of intermittent monitoring of mixed venous oxygen saturation after stage 1 palliation for hypoplastic left heart syndrome. Am J Cardiol 1994, 73:1118-1123.
64. Tweddell JS, Hoffman GM, Fedderly RT, et al.: Phenoxybenzamine improves systemic oxygen delivery after the Norwood procedure. Ann Thorac Surg 1999, 67:161-168.
65. Hoffman GM, Ghanayem NS, Kampine JM, et al.: Venous saturation and anaerobic threshold in neonates after the Norwood procedure for hypoplastic left heart syndrome. Ann Thorac Surg 2000, 70:1515-1521.
66. Seigel LB, Dalton HJ, Hertzog JH, et al.: Initial postoperative serum lactate levels predict survival in children after open-heart surgery. Intensive Care Med 1996, 22:1418-1423.
67. Hatherill M, Sajjanhar T, Tibby SM, et al.: Serum lactate as a predictor of mortality after pediatric cardiac surgery. Arch Dis Child 1997, 77:235-238.
68. Duke T, Butt W, South M, et al.: Early markers of major adverse events in children after cardiac operations. J Thorac Cardiovasc Surg 1997, 114:1042-1052.
69. Cheifetz IM, Kern FH, Schulman SR, et al.: Serum lactates correlate with mortality after operations for complex congenital heart disease. Ann Thorac Surg 1997, 64:735-738.
70. Kalkman JJ, Otte JA, Groeneveld AB, et al.: Gastrointestinal luminal PCO2 tonometry: an update on physiology, methodology and clinical applications. Br J Anaesth 2000, 84:74-86.
71. Friedman WF, George BL: Treatment of congestive heart failure by altering loading conditions of the head. J Pediatr 1985, 106:697.
72. Bohn DJ, Poirer CS, Edmonds JF, et al.: Efficacy of dopamine, dobutamine and epinephrine during emergence from cardiopulmonary bypass in children. Crit Care Med 1980, 8:367.
73. Habib DM, Padbury JF, Anas NG: Dobutamine pharmacokinetics and pharmacodynamics in pediatric intensive care patients. Crit Care Med 1992, 20:601-608.
74. Berg RA, Donnerstein RL, Padbury JF: Dobutamine infusions in stable, critically ill children: pharmacokinetics and hemodynamic actions. Crit Care Med 1993, 21:678-686.
75. Caspi J, Coles JG, Benson LN, et al.: Effects of high plasma epinephrine and Ca2+ concentrations on neonatal myocardial function after ischemia. J Thorac Cardiovasc Surg 1993, 105:59-67.
76. Caspi J, Coles JG, Benson LN, et al: Age-related response to epinephrine-induced myocardial stress: a functional and ultrastructural study. Circulation 1991, 84 (suppl III):III-394-III-399
77. Rosenzweig EB, Starc TJ, Chen JM, et al.: Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation 1999, 100:182-186.
78. Murzi B, Iervasi G, Masini S, et al.: Thyroid hormones homeostasis in patients during and after cardiopulmonary bypass. Ann Thorac Surg 1995, 59:481-485.
79. Bettendorf M, Schmidt KG, Tiefenbacher U, et al.: Transient secondary hypothyroidism in children after cardiac surgery. Pediatr Res 1997, 41:375-379.
80. Mainwaring RD, Capparelli B, Schell K, et al.: Pharmacokinetic evaluation of triiodothyronine supplementation in children after modified Fontan procedure. Circulation 2000, 101:1423-1429.
81. Bettendorf M, Schmidt KG, Grulich-Henn J, et al.: Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomized, placebo-controlled study. Lancet 2000, 356:529-534.
82. Portman MA, Fearneyhough C, Ning X, et al.: Triiodothyronine repletion in infants during cardiopulmonary bypass for congenital heart disease. J Thorac Cardiovasc Surg 2000, 120:604-608.
83. Chowdhury D, Ojamae K, Parnell VA, et al.: A prospective randomized clinical study of thyroid hormone treatment after operations for complex congenital heart disease. J Thorac Cardiovasc Surg 2001, 122:1023-1025.
84. Carrel T, Eckstein F, Englberger L, et al.: Thyronine treatment in adult and pediatric heart surgery: clinical experience and review of literature. Eur J Heart Failure 2002, 4:577-582.
85. Dupuis JY, Bondy R, Cattran C, et al.: Amrinone and dobutamine as primary treatment of low cardiac output syndrome following coronary artery surgery: a comparison of their effects on hemodynamics and outcome. J Cardiothorac Vasc Anesth 1992, 6:542-553.
86. Robinson BW, Gelband H, Mas MS: Selective pulmonary and systemic vasodilator effects of amrinone in children: new therapeutic implications. J Am Coll Cardiol 1993, 21:1461-1465.
87. Berner M, Jaccard C, Oberhansli I: Hemodynamic effects of amrinone in children after cardiac surgery. Intensive Care Med 1990, 16:85-88.
88. Bailey JM, Miller BE, Lu W, et al.: The pharmacokinetics of milrinone in pediatric patients after cardiac surgery. Anesthesiology 1999, 90:1012-1018.
89. Ramamoorthy C, Anderson GD, Williams GD, et al.: Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery. Anesth Analg 1998, 86:283-289.
90. Chang AC, Atz AM, Wernovsky G, et al.: Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 1995, 23:1907-1914.
91. Hoffman TM, Wernovsky G, Atz AM, et al.: Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Am Heart J 2002, 143:15-21.
92. Hoffman TM, Wernovsky G, Atz AM, et al.: Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003, 107:996-1002. This study represents one of the largest multicenter, randomized trials in a pediatric cardiac surgical population. The high-dose milrinone group demonstrated a 66% relative risk reduction in the development of LCOS after cardiac surgery, with a safety profile similar to placebo.
93. Hickey PR, Hansen DD: Pulmonary hypertension in infants: postoperative management. In Annual of Cardiac Surgery. Edited by Yacoub M. London: Current Science; 1989:16-22.
94. Wheller J, George BL, Mulder DG, et al.: Diagnosis and management of postoperative pulmonary hypertensive crisis. Circulation 1979, 70:1640-1644.
95. Jones ODH, Shore DF, Rigby ML, et al.: The use of tolazoline hydrochloride as a pulmonary vasodilator in potentially fatal episodes of pulmonary vasoconstriction after cardiac surgery in children. Circulation 1981, 64:134-139.
96. Drummond WH, Gregory GA, Heymann MA, et al.: The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertension. J Pediatr 1981, 98:603-611.
97. Furchgott RF: The role of endothelium in the responses of vascular smooth muscle to drugs. Ann Rev Pharmacol Toxicol 1984, 24:175-197.
98. Ignarro LJ, Buga GM, Wood KS, et al.: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987, 84:9265-9269.
99. Wessel DL, Adatia I, Giglia TM, et al.: Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993, 88:2128-2138.
100. Journois D, Pouard P, Mauriat P, et al.: Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 1994, 107:1129-1135.
101. Luciani GB, Chang AC, Starnes VA: Surgical repair of transposition of the great arteries in neonates with persistent pulmonary hypertension. Ann Thorac Surg 1996, 61:800-805.
102. Adatia I, Perry S, Moore P, et al.: Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. J Am Coll Cardiol 1995, 25:1652-1664.
103. Wessel DL, Adatia I, Marter LJV, et al.: Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 1997, 100:1-7.
104. Yahagi N, Kumon K, Tanigami H, et al.: Inhaled nitric oxide for the postoperative management of Fontan-type operations. Ann Thorac Surg 1994, 57:1371-1372.
105. Atz AM, Munoz RA, Adatia I, et al.: Diagnostic and therapeutic uses of inhaled nitric oxide in neonatal Ebstein's anomaly. Am J Cardiol 2003, 91:906-908. This brief report describes the usefulness of inhaled NO in differentiating between functional and anatomic pulmonary atresia in neonatal Ebstein's anomaly.
106. Atz AM, Adatia I, Wessel DL: Rebound pulmonary hypertension after inhalation of nitric oxide. Ann Thorac Surg 1996, 62:1759-1764.
107. Atz AM, Wessel DL: Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 1999, 91:307-310.
108. Adatia I: Recent advances in pulmonary vascular disease. Curr Opin Pediatr 2002, 14:292-297. This article is a comprehensive review of recent advances in the understanding of the genetics and treatment of pulmonary hypertension.
109. Runo JR, Loyd JE: Primary pulmonary hypertension. Lancet 2003, 361:1533-1544. This review discusses the epidemiology, pathophysiology, diagnosis, treatment, and prognosis of patients with primary pulmonary hypertension.
110. Barst RJ, Rubin LJ, McGoon MD, et al.: Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann Intern Med 1994, 121:409-415.
111. Barst RJ, Rubin LJ, Long WA, et al.: A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996, 334:296-302.
112. Barst RJ, McGoon M, McLaughlin V, et al.: Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol 2003, 41:2119-2125. This multicenter, randomized, double-blind, placebo-controlled trial of 116 patients with pulmonary hypertension evaluated the efficacy and safety of beraprost. Patients treated with beraprost had improved exercise tolerance and less evidence of disease progression at 6 months compared with placebo-treated patients, but these effects were not evident at 12 months. These data suggest that the beneficial effects of beraprost attenuate with time.
113. Rimensberger PC, Spahr-Schopfer I, Berner M, et al.: Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease. Circulation 2001, 103:544-548.
114. Olschewski H, Ghofrani A, Schmehl T, et al.: Inhaled iloprost to treat severe pulmonary hypertension. Ann Intern Med 2000, 132:435-443.
115. Prasad S, Wilkinson J, Gatzoulis MA: Sildenafil in primary pulmonary hypertension. N Engl J Med 2000, 343:1342-1343.
116. Abrams D, Schulze-Nieck I, Magee AG: Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Heart 2000, 84:e4-e5.
117. Zhao L, Mason NA, Morrell NW: Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation 2001, 104:424-428.
118. Atz AM, Lefler AK, Fairbrother DC: Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises. J Thorac Cardiovasc Surg 2002, 124:628-629. This case report describes the synergistic effects of NO and sildenafil in the treatment of pulmonary hypertension after mitral valve surgery.
119. Schulze-Niecke I, Dietz P, Stiller B, et al.: Sildenafil is a potent pulmonary vasodilator in children after heart surgery [abstract]. Circulation 2002, 19(suppl 2):396. This is the only study (abstract only) describing the use of intravenous sildenafil. In a small group of children after cardiac surgery, intravenous sildenafil decreased pulmonary vascular resistance to a greater degree than inhaled NO or supplemental oxygen.
120. Bharani A, Mathew V, Sahu A, et al.: The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension. Indian Heart J 2003, 55:55-59. In a small group of patients with pulmonary hypertension of varied etiology, oral sildenafil improved exercise tolerance as determined by the 6-minute walk and decreased Doppler estimated pulmonary artery pressure compared with placebo. Sildenafil was well tolerated in all patients.
121. Sastry BK, Narasimhan C, Reddy NK, et al.: A study of clinical efficacy of sildenafil in patients with primary pulmonary hypertension. Indian Heart J 2002, 54:410-414. This is another study from India in which oral sildenafil improved exercise tolerance and decreased pulmonary artery pressures in patients with pulmonary hypertension. Although 19 of 31 historical control subjects died during the study period, only 1 of 29 patients treated with sildenafil died during follow-up (range, 5 to 20 months).
122. Channick RN, Simonneau G, Sitbon O, et al.: Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebo-controlled study. Lancet 2001, 358:1119-1123.
123. Galie N, Hinderliter AL, Torbicki A, et al.: Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary artery hypertension. J Am Coll Cardiol 2003, 16:1380-1386. In a multicenter, randomized trial of 85 patients with World Health Organization class 3 or 4 pulmonary hypertension, treatment with bosentan resulted in better exercise tolerance as determined by the 6-minute walk, improved right ventricular systolic function, and less right ventricular dilatation.
124. Barst RJ, Ivy D, Dingemanse J, et al.: Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension. Clin Pharmacol Ther 2003, 73:372-373. This open-label, noncontrolled trial enrolled 19 children with pulmonary hypertension. According to this study the pharmacokinetics of bosentan in pediatric patients with pulmonary hypertension and healthy adults are similar, and bosentan is well tolerated.
125. Boucek MM, Edward LB, Berkeley MK, et al.: The registry of the International Society for Heart and Lung Transplantation: sixth official pediatric report-2003. J Heart Lung Transplant 2003, 22:636-652. The sixth annual report of the pediatric registry of the International Society for Heart and Lung Transplantation describes the cumulative international experience with pediatric thoracic organ transplantation. Besides providing survival statistics, this report describes factors that are associated and not associated with 1-year and 5-year survival, evolving trends in induction therapy and maintenance immunosuppression.
126. Clabby ML, Canter CE, Mollen JH, et al.: Hemodynamic data and survival in children with pulmonary hypertension. J Am Coll Cardiol 1997, 30:554-560.
127. Gaynor JW, Bridges ND, Clark BJ, et al.: Update on lung transplantation in children. Curr Opin Pediatr 1998, 10:256-261.
128. Braunstein PW, Sade RM, Gillette PC, et al.: Life-threatening postoperative junctional ectopic tachycardia. Ann Thorac Surg 1992, 53:726-728.
129. Perry JC, Fenrich AL, Hulse JE, et al.: Pediatric use of intravenous amiodarone: efficacy and safety in critically ill patients from a multicenter protocol. J Am Coll Cardiol 1996, 27:1246-1250.
130. Hoffman TM, Wernovsky G, Wieand G, et al.: The incidence of arrhythmias in a pediatric intensive care unit. Pediatr Cardiol 2002, 23:598-604. This report describes the incidence of arrhythmias in 629 patients admitted over a one-year period to the cardiac intensive care unit at the Children's Hospital of Philadelphia. Patients were evaluated by full disclosure telemetry reviewed every 24 hours. Overall, 29% of admissions had one or more arrhythmias, the most common arrhythmia was nonsustained ventricular tachycardia (VT) (18%), followed by nonsustained supraventricular tachycardia (SVT) (12.9%).
131. Hoffman TM, Bush DM, Wernovsky G, et al.: Postoperative junctional ectopic tachycardia in children: incidence, risk factors, and treatment. Ann Thorac Surg 2002, 74:1607-1611. This single-center study evaluated factors associated with postoperative JET in pediatric cardiac surgical patients. JET occurred in 5.6% of 594 patients who underwent cardiac operations from December 1997 through November 1998. By multivariate analysis, dopamine use postoperatively and in infants younger than 6 months was associated with JET.
132. Klinge JM, Scharf J, Hofbeck M, et al: Intermittent administration of furosemide versus continuous infusion in the postoperative management of children following open heart surgery. Intensive Care Med 1997, 23:693-697.
133. Van der Vorst MM, Ruys-Dudok VI, Kist-van Holthe JE, et al: Continuous intravenous furosemide in hemodynamically unstable children after cardiac surgery. Intensive Care Med 2001, 27:711-715.
134. Marik PE: Low-dose dopamine: a systematic review: Intensive Care Med 2002, 28:877-883.
135. Hughes AD, Sever PS: Action of fenoldopam, a selective dopamine (DA1) receptor agonist, on isolated human arteries. Blood Vessels 1989, 26:119-127.
136. Strauser LM, Pruitt RD, Tobias J: Initial experience with fenoldopam in children. Am J Ther 1999, 6:283-288.
137. Bridges ND, Mayer JE Jr, Lock JE, et al.: Effect of baffle fenestration on outcome of the modified Fontan operation. Circulation 1992, 86:1762-1769.
138. Lemler MS, Scott WA, Leonard SR, et al.: Fenestration improves clinical outcome of the Fontan procedure: a prospective randomized study. Circulation 2002, 105:207-212.
139. Duncan BW, Bohn DJ, Atz AM, et al.: Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg 2001, 122:440-448.
140. Duncan BW: Mechanical circulatory support for infants and children with cardiac disease. Ann Thorac Surg 2002, 73:1670-1677.
141. Davies JE, Kirklin JK, Pearce FB, et al.: Mechanical circulatory support for myocarditis: how much recovery should occur before device removal. J Heart Lung Transplant 2002, 21:1246-1249. A case report describing the successful use of biventricular assist devices for presumed myocarditis.
142. Levi D, Marelli D, Plinkett M, et al.: Use of assist devices and ECMO to bridge pediatric patients with cardiomyopathy to transplantation. J Heart Lung Transplant 2002, 21:760-770. This study reports the experience with the use of ECMO as a bridge to heart transplantation in a large, pediatric tertiary care center. Nineteen patients were supported with ECMO or centrifugal VADs, and nine received pulsatile support (BVS 5000, Thoratec). A total of 68% of patients were successfully bridged to transplant or weaned off mechanical support. Of the patients bridged to transplant or recovery, 89% are alive to date. Patients with pulsatile VADs had significantly higher rates of extubation and oral feeding.
143. Gajarski RJ, Mosca RS, Ohye RG, et al.: Use of extracorporeal life support as a bridge to pediatric cardiac transplantation. J Heart Lung Transplant 2003, 22:28-34. This is a descriptive report of the outcome of children needing extracorporeal life support (ECLS) in a large pediatric tertiary center. Of 145 patients with ventricular failure who received ECLS, 21 were listed for heart transplantation. Of the non-listed patients, 57 patients (46%) were weaned from ECLS and survived. Of the 21 patients listed for heart transplantation, five were weaned from ECLS and did not require heart transplantation, and 12 were successfully bridged to heart transplantation. Of 11 infants, four were weaned from ECLS without heart transplantation, five were bridged to transplantation, and two died.
144. Kirshbom PM, Bridges ND, Myung RJ, et al.: Use of extracorporeal membrane oxygenation in pediatric thoracic organ transplantation. J Thorac Cardiovasc Surg 2002, 123:130-136.
145. Booth KL, Roth SJ, Perry SB, et al.: Cardiac catheterization of patients supported by extracorporeal membrane oxygenation. J Am Coll Cardiol 2002, 40:1681-1686. This study was a retrospective review of the indications and outcome of all patients catheterized on ECMO. Sixty catheterizations were performed in 54 patients. Interventions performed included left heart decompression in 12 patients, catheter-based interventions in six patients, and arrhythmia ablation in three patients. Complications were two myocardial perforations that were treated with pericardial drains. This study shows the feasibility and safety of performing diagnostic and interventional catheterization in a large pediatric tertiary care center.
146. Hetzer R, Loebe M, Weng Y, et al.: Pulsatile pediatric assist devices: current results for bridge to transplantation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 1999, 2:157-176.
147. Reinhartz O, Keith FM, El-Banayosy A, et al.: Multicenter experience with the Thoratec ventricular assist device in children and adolescents. J Heart Lung Transplant 2001, 20:439-448.
148. Reinhertz O, Stiller B, Eilers R, et al.: Current clinical status of pulsatile pediatric circulatory support. ASAIO J 2002, 48:455-459. This excellent review summarizes the worldwide experience with VADs in children.
149. Young JB, Abraham WT, Smith AL, et al.: Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. JAMA 2003, 289:2685-2694. In a randomized, double-blind study, 187 patients in New York Heart Association class 3 or 4 with a left ventricular ejection fraction of 35% or less and a QRS duration of 130 msec were randomized to cardiac resynchronization therapy. Patients assigned to cardiac resynchronization therapy had greater improvement in functional class and exercise capacity.
150. Janousek J, Chaloupecky V, Hucin B, et al.: Hemodynamically optimized temporary cardiac pacing after surgery for congenital heart defects. Pacing Clin Electrophysiol 2000, 23:1250-1259.
151. Bronicki RA, Backer CL, Baden HP, et al.: Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg 2000, 69:1490-1495.
152. Lodge AJ, Chai PJ, Daggett CW, et al.: Methylprednisolone reduces the inflammatory response to cardiopulmonary bypass in neonatal piglets: timing of dose is important. J Thorac Cardiovasc Surg 1999, 117:515-522.
153. Kawamura T, Inada K, Nara N, et al.: Influence of methylprednisolone on cytokine balance during cardiac surgery. Crit Care Med 1999, 27:545-548.
154. Jansen NJG, Van Oeveren W, Van Vliet M, et al.: The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass. Eur J Cardiothorac Surg 1991, 5:211-217.
155. Checchia PA, Backer CL, Bronicki RA, et al.: Dexamethasone reduces postoperative troponin levels in children undergoing cardiopulmonary bypass. Crit Care Med 2003, 31:1742-1745. In a prospective, randomized, double-blind study, 28 children undergoing open heart surgery received either placebo or dexamethasone 1 mg/kg 1 hour before CPB. Mean cardiac troponin I levels at 24 hours were significantly lower in the dexamethasone group compared with the control group.
156. Tassani P, Kunkel R, Richer JA, et al.: Effect of C1-esterase inhibitor on capillary leak and inflammatory response syndrome during arterial switch operations in neonates. J Cardiothorac Vasc Anesth 2001, 15:469-473.
157. Van Houten JP, Rothman A, Bejar R: High incidence of cranial ultrasound abnormalities in full-term infants with congenital heart disease. Am J Perinatol 1996, 13:47-53.
158. Kramer HH, Majewski F, Trampisch HJ, et al.: Malformation patterns in children with congenital heart disease. Am J Dis Child 1987, 141:789-795.
159. Mahle WT, Tavani F, Zimmerman RA, et al.: An MRI study of neurological injury before and after congenital heart surgery. Circulation 2002, 106(suppl 1):109-114. In a prospective MRI study in 24 neonates with congenital heart disease, mild ischemic lesions primarily in the form of periventricular leukomalacia were detected in 24% of patients before surgery and in more than 50% of patients after surgery. The majority of the lesions resolved 4 to 6 months after surgery.
160. Rappaport LA, Wypij D, Bellinger DC, et al.: Relation of seizures after cardiac surgery in early infancy to neurodevelopmental outcome. Circulation 1998, 97:773-779.
161. Mahle WT, Clancy RR, Moss E, et al.: Neurodevelopmental outcome and lifestyle assessment in school-age and adolescent children with hypoplastic left heart syndrome. Pediatrics 2000, 105:1085-1092.
162. Limperopoulos C, Majnemer A, Shevell MI, et al.: Neurologic status of newborns with congenital heart defects before open heart surgery. Pediatrics 1999, 103:402-408.
163. Clancy RR, McGaura SA, Wernovsky G, et al.: Risk of seizures in survivors of newborn heart surgery using deep hypothermic circulatory arrest. Pediatrics 2003, 111:592-601. A total of 164 infants who were enrolled in a single-center neurocardiac protection trial formed a comprehensive database for the evaluation of preoperative and intraoperative variables that influence the postoperative occurrence of seizures. Seizures occurred in 19% of patients. Using logistic regression, the three variables that were found to be associated with the occurrence of seizures were genetic conditions, presence of aortic
164. Forbess JM, Visconti KJ, Bellinger DC: Neurodevelopmental outcomes in children after the Fontan operation. Circulation 2001, 104(suppl 1):I-127-I-32.
165. Hicks RJ, Poole JL: Electroencephalographic changes with hypothermia and cardiopulmonary bypass in children. J Thorac Cardiovasc Surg 1981, 81:781-786.
166. Bashein G, Nessly ML, Bledsoe SW, et al.: Electroencephalography during surgery with cardiopulmonary bypass and hypothermia. Anesthesiology 1992, 76:878-891.
167. Laussen PC, Murphy JA, Zurakowski D, et al.: Bispectral index monitoring in children undergoing mild hypothermic cardiopulmonary bypass. Paediatr Anaesth 2001, 11:567-573.
168. Hayashida M, Chinzei M, Komatsu K, et al.: Detection of cerebral hypoperfusion with bispectral index during paediatric cardiac surgery. Br J Anaesth 2003, 90:694-698. BIS and cerebral oxygen saturation by near-infrared spectroscopy were measured in 10 children undergoing cardiac surgery for noncyanotic heart disease. In 5 of the 10 children, acute hypotension was associated with a simultaneous decrease in BIS and cerebral oxygen saturation, indicating cerebral hypoperfusion.
169. Zabala L, Ahmed MI, Denman WT: Bispectral index in a 3-year old undergoing deep hypothermia and circulatory arrest. Paediatr Anaesth 2003, 13:355-359. In this case report, BIS declined with the gradual onset of hypothermia and circulatory arrest, and remained low during the rewarming phase of CPB. Once fully awake, the patient was successfully extubated and discharged home with no evidence of neurologic dysfunction.
170. Daubeney PE, Pilkington SN, Janke E: et al: Cerebral oxygenation measured by near-infrared spectroscopy: comparison with jugular bulb oximetry. Ann Thorac Surg 1996, 61:930-934.
171. Austin EH, Edmonds HL, Auden SM, et al.: Benefit of neurophysiologic monitoring for pediatric cardiac surgery. J Thorac Cardiovasc Surg 1997, 114:707-717.
172. Zimmerman AA, Burrows FA, Jonas RA, et al.: The limits of detectable cerebral perfusion by transcranial Doppler sonography in neonates undergoing deep hypothermic low-flow cardiopulmonary bypass. J Thorac Cardiovasc Surg 1997, 114:594-600.
173. Kurth CD, Steven JL, Montenegro LM, et al.: Cerebral oxygen saturation before congenital heart surgery. Ann Thorac Surg 2001, 72:187-192.
174. Yoshitani K, Kawaguchi M, Tatsumi K, et al.: A comparison of the INVOS 4100 and the NIRO 300 near-infrared spectrophotometers. Anesth Analg 2002, 94:586-590.
175. Andropoulos DB, Stayer SA, McKenzie DE, et al: Novel cerebral physiologic monitoring to guide low-flow cerebral perfusion during neonatal aortic arch reconstruction. J Thorac Cardiovasc Surg 2003, 125:491-499. In a prospective study, cerebral oxygen saturation and blood flow velocity were measured by near-infrared spectroscopy and transcranial Doppler respectively in 34 patients undergoing neonatal aortic arch reconstruction with regional low-flow perfusion. Mean arterial pressure had a poor correlation with the required bypass flow rate. Fourteen of 34 patients had a cerebral oxygen saturation of 95%, placing them at risk for cerebral hyperperfusion if the cerebral oxygen saturation had been used alone to guide bypass flow.